OurMemos will be able to provide regular cognitive assessments to the 42.3 million domestic seniors 65 and over that say it’s important to have their memory checked regularly, of which only 8.3 million get it done. With an estimated 5.8 million Americans living with Alzheimer’s Disease in 2019, projecting to grow to 14 million by 2060, it’s critical that researchers have access to a variety of data elements to investigate new therapies to slow the disease’s progression. Unfortunately, nearly all research advances have failed in human clinical trials. OurMemos Memory Module application monitors and assess daily functions of individuals with cognitive decline, Alzheimer’s Disease and/or Alzheimer’s Disease related dementia.